BioSpace News Archive

INVO Bioscience, Inc. today announced that Dr. Sue Ellen Carpenter of Bloom Fertility, the Company’s Atlanta-based INVO Center, was named a recipient of the Castle Connolly Top Doctor Award for 2023.

NovAccess Global Inc., a biomedical company developing novel immunotherapies for brain tumor patients, announced that the Securities and Exchange Commission has declared the Company’s registration statement on Form S-1 effective as of September 16, 2022.

Medical device and technology company Lazurite™ Holdings LLC announced today that it is working with LG Electronics USA as a reseller of LG’s high-performance surgical display monitors.

The American Diabetes Association® announced a new initiative designed to address the urgent public health challenge of preventable amputation called the Amputation Prevention Alliance.

Dynarex Corporation, a leading durable medical equipment and disposable medical products company, is proud to honor Lainey Volk as the 2022 recipient of the Dynarex EMS First Responder Caring Award.

DyAnsys, Inc., has announced that Primary Relief, a percutaneous electrical neurostimulation device, has been approved to treat pain following a cardiac surgery.

The latest market analysis report published by Reports and Data, titled ‘Global Myofascial Pain Syndrome Market – Forecast to 2030,’ thoroughly examines the Myofascial Pain Syndrome industry to provide essential data & information for the targeted readers.

Scientists at the Allen Institute are launching the brain equivalent of the Human Genome Project, leading a new global collaboration to map the approximately 200 billion cells in the human brain by their type and function.

Invitae (NYSE: NVTA), a leading medical genetics company, released a new study in JAMA Network Open, underscoring the clinical utility of the American Society of Breast Surgeons (ASBrS) guidelines recommending universal genetic testing for patients with breast cancer, and showing universal testing improves patient outcomes.

The global whole exome sequencing market size is expected to reach USD 4.2 billion by 2025 from USD 1.5 billion in 2020, at a CAGR of 25.1%.